Genialis and Debiopharm expand collaboration to develop RNA-based predictive biomarkers for DDR therapies, advancing precision oncology.

DDR is a promising arena for the development of precision ... enables rapid configuration of biomarkers across the entire landscape of cancer drug targets, including DDR. Trained on hundreds ...

The Alzheimer’s Association advised against diagnosing the disease on biomarkers alone, but other experts said the genie ...

This investigational drug is being evaluated both as ... noted the critical need for predictive biomarkers in DDR therapy development. The Genialis Supermodel, which has been instrumental in ...

Identification and qualification of pharmacogenomic biomarkers of adverse drug reaction (ADR) susceptibility will eventually permit the prediction of risk and the development of rational risk ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

SINGAPORE, January 23, 2025 /EINPresswire / -- KYAN Technologies Pte. Ltd. (“KYAN”) announces the publication of study results in Experimental Hematology & Oncology, with the publication ...